Comments
Strides Arcolab has informed the BSE that it has allotted 2.10 crore shares of ₹10 each to the shareholders of erstwhile Shasun Pharmaceuticals, in the ratio of five shares of ₹10 each of Strides Arcolab for every 16 shares of Shasun. The allotment was decided at the meeting of the allotment committee of the Board of Directors on November 20, . Consequent to this allotment, the paid-up equity share capital of the company has increased to ₹80.642 crore from ₹59.625 crore. S Abhaya Kumar, CEO of erstwhile Shasun, has been appointed Executive Director of the company from November 19.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.